39 related articles for article (PubMed ID: 15746850)
1. Overexpression of MMP-2 in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis.
Liu WW; Zeng ZY; Wu QL; Hou JH; Chen YY
Otolaryngol Head Neck Surg; 2005 Mar; 132(3):395-400. PubMed ID: 15746850
[TBL] [Abstract][Full Text] [Related]
2. A practical online prediction platform to predict the survival status of laryngeal squamous cell carcinoma after 5 years.
Li Z; Li T; Zhang P; Wang X
Am J Otolaryngol; 2024; 45(3):104209. PubMed ID: 38154199
[TBL] [Abstract][Full Text] [Related]
3. Protein expression analysis for predicting recurrent laryngeal squamous cell carcinoma.
Thanasan S; Ruangritchankul K; Kitkumthorn N; Keelawat S; Mahattanasakul P
Biomed Rep; 2024 Jan; 20(1):15. PubMed ID: 38124771
[TBL] [Abstract][Full Text] [Related]
4. Antitumor Effects of Carvacrol and Thymol: A Systematic Review.
Sampaio LA; Pina LTS; Serafini MR; Tavares DDS; Guimarães AG
Front Pharmacol; 2021; 12():702487. PubMed ID: 34305611
[No Abstract] [Full Text] [Related]
5. Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma.
Matulka M; Konopka A; Mroczko B; Pryczynicz A; Kemona A; Groblewska M; Sieskiewicz A; Olszewska E
Dis Markers; 2019; 2019():3136792. PubMed ID: 31143300
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases (MMPs) and inhibitor of metalloproteinases (TIMP) mRNA and protein expression in laryngeal squamous cell carcinoma.
Grzelczyk WL; Wróbel-Roztropiński A; Szemraj J; Cybula M; Pietruszewska W; Zielińska-Kaźmierska B; Jozefowicz-Korczynska M
Arch Med Sci; 2019 May; 15(3):784-791. PubMed ID: 31110546
[TBL] [Abstract][Full Text] [Related]
7. Andrographolide enhances the anti-metastatic effect of radiation in Ras-transformed cells via suppression of ERK-mediated MMP-2 activity.
Yu CC; Chen CA; Fu SL; Lin HY; Lee MS; Chiou WY; Su YC; Hung SK
PLoS One; 2018; 13(10):e0205666. PubMed ID: 30359388
[TBL] [Abstract][Full Text] [Related]
8. Identification of gene expression models for laryngeal squamous cell carcinoma using co-expression network analysis.
Yang CW; Wang SF; Yang XL; Wang L; Niu L; Liu JX
Medicine (Baltimore); 2018 Feb; 97(7):e9738. PubMed ID: 29443735
[TBL] [Abstract][Full Text] [Related]
9. Early detection of squamous cell carcinoma in carcinogen induced oral cancer rodent model by ratiometric activatable cell penetrating peptides.
Hingorani DV; Lemieux AJ; Acevedo JR; Glasgow HL; Kedarisetty S; Whitney MA; Molinolo AA; Tsien RY; Nguyen QT
Oral Oncol; 2017 Aug; 71():156-162. PubMed ID: 28688684
[TBL] [Abstract][Full Text] [Related]
10. May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer?
Shrestha B; Bajracharya D; Byatnal AA; Kamath A; Radhakrishnan R
Pathol Oncol Res; 2017 Jan; 23(1):197-206. PubMed ID: 27853937
[TBL] [Abstract][Full Text] [Related]
11. Identification of key genes for laryngeal squamous cell carcinoma using weighted co-expression network analysis.
Li XT
Oncol Lett; 2016 May; 11(5):3327-3331. PubMed ID: 27123111
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase 2 (MMP2) protein expression and laryngeal cancer prognosis: a meta analysis.
Liu RR; Li MD; Li T; Tan Y; Zhang M; Chen JC
Int J Clin Exp Med; 2015; 8(2):2261-6. PubMed ID: 25932160
[TBL] [Abstract][Full Text] [Related]
13. Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma.
Raju SC; Hauff SJ; Lemieux AJ; Orosco RK; Gross AM; Nguyen LT; Savariar E; Moss W; Whitney M; Cohen EE; Lippman SM; Tsien RY; Ideker T; Advani SJ; Nguyen QT
Oral Oncol; 2015 May; 51(5):470-5. PubMed ID: 25735654
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of Expression of Matrix Metalloproteinases (MMP-2 and MMP-9) in Glottic Squamous Cell Carcinoma and Benign Vocal Fold Lesions.
Uloza V; Liutkevicius V; Pangonyte D; Lesauskaite V
Clin Exp Otorhinolaryngol; 2015 Mar; 8(1):57-64. PubMed ID: 25729497
[TBL] [Abstract][Full Text] [Related]
15. Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice.
Hauff SJ; Raju SC; Orosco RK; Gross AM; Diaz-Perez JA; Savariar E; Nashi N; Hasselman J; Whitney M; Myers JN; Lippman SM; Tsien RY; Ideker T; Nguyen QT
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):612-8. PubMed ID: 25091190
[TBL] [Abstract][Full Text] [Related]
16. Pre-treatment gelatinases' serum levels and post-treatment changes in laryngeal cancer patients.
Tsiropoulos G; Papadas T; Triantaphyllidou Ie; Naxakis S; Markou K; Triaridis S; Vital I; Goumas P; Vynios D
Hippokratia; 2013 Jul; 17(3):220-7. PubMed ID: 24470731
[TBL] [Abstract][Full Text] [Related]
17. Real-time in vivo molecular detection of primary tumors and metastases with ratiometric activatable cell-penetrating peptides.
Savariar EN; Felsen CN; Nashi N; Jiang T; Ellies LG; Steinbach P; Tsien RY; Nguyen QT
Cancer Res; 2013 Jan; 73(2):855-64. PubMed ID: 23188503
[TBL] [Abstract][Full Text] [Related]
18. MMP-2 expression in 102 patients with glottic laryngeal cancer.
Mallis A; Teymoortash A; Mastronikolis NS; Werner JA; Papadas TA
Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):639-42. PubMed ID: 21667117
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases (MMP-2 and MMP-9) in recurrent respiratory papillomas and laryngeal carcinoma: clinical and morphological parallels.
Uloza V; Liutkevičius V; Pangonytė D; Saferis V; Lesauskaitė V
Eur Arch Otorhinolaryngol; 2011 Jun; 268(6):871-8. PubMed ID: 21259063
[TBL] [Abstract][Full Text] [Related]
20. MMP-14 can serve as a prognostic marker in patients with supraglottic cancer.
Zhang H; Liu M; Sun Y; Lu J
Eur Arch Otorhinolaryngol; 2009 Sep; 266(9):1427-34. PubMed ID: 19283401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
